Schrodinger (STU:43Z) FCF Margin % : -36.22% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Schrodinger FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Schrodinger's Free Cash Flow for the three months ended in Dec. 2024 was €-30.5 Mil. Schrodinger's Revenue for the three months ended in Dec. 2024 was €84.3 Mil. Therefore, Schrodinger's FCF Margin % for the quarter that ended in Dec. 2024 was -36.22%.

As of today, Schrodinger's current FCF Yield % is -10.51%.

The historical rank and industry rank for Schrodinger's FCF Margin % or its related term are showing as below:

STU:43Z' s FCF Margin % Range Over the Past 10 Years
Min: -79.35 Med: -49.95 Max: 13.15
Current: -78.68

During the past 8 years, the highest FCF Margin % of Schrodinger was 13.15%. The lowest was -79.35%. And the median was -49.95%.

STU:43Z's FCF Margin % is ranked worse than
90.33% of 672 companies
in the Healthcare Providers & Services industry
Industry Median: 2.175 vs STU:43Z: -78.68

Schrodinger FCF Margin % Historical Data

The historical data trend for Schrodinger's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schrodinger FCF Margin % Chart

Schrodinger Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

13.15

-56.43

-70.57

-69.29

-79.35

Schrodinger Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-53.60	-118.51	-115.61	-98.04	-36.22

Competitive Comparison of Schrodinger's FCF Margin %

For the Health Information Services subindustry, Schrodinger's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schrodinger's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Schrodinger's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Schrodinger's FCF Margin % falls into.

Schrodinger FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Schrodinger's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-157.268	/	198.2
	=	-79.35 %

Schrodinger's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-30.547	/	84.343
	=	-36.22 %

Schrodinger FCF Margin % Related Terms

Thank you for viewing the detailed overview of Schrodinger's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Schrodinger Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Schrodinger Inc (STU:43Z) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SDGR:USA

Address

1540 Broadway, 24th Floor, New York, NY, USA, 10036

Website

https://www.schrodinger.com

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Schrodinger Headlines

No Headlines